Literature DB >> 12527361

Glucosamine-induced insulin resistance is coupled to O-linked glycosylation of Munc18c.

Guoli Chen1, Ping Liu, Debbie C Thurmond, Jeffrey S Elmendorf.   

Abstract

Evidence suggests that glucosamine inhibits distal components regulating insulin-stimulated GLUT4 translocation to the plasma membrane. Here we assessed whether key membrane docking and fusion events were targeted. Consistent with a plasma membrane-localized effect, 3T3-L1 adipocytes exposed to glucosamine displayed an increase in cell-surface O-linked glycosylation and a simultaneously impaired mobilization of GLUT4 by insulin. Analysis of syntaxin 4 and SNAP23, plasma membrane-localized target receptor proteins (t-SNAREs) for the GLUT4 vesicle, showed that they were not cell-surface targets of O-linked glycosylation. However, the syntaxin 4 binding protein, Munc18c, was targeted by O-linked glycosylation. This occurred concomitantly with a block in insulin-stimulated association of syntaxin 4 with its cognate GLUT4 vesicle receptor protein (v-SNARE), VAMP2. In conclusion, our data suggest that the mechanism by which glucosamine inhibits insulin-stimulated GLUT4 translocation involves modification of Munc18c.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527361     DOI: 10.1016/s0014-5793(02)03774-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  Fluidity of insulin action.

Authors:  Jeffrey S Elmendorf
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

Review 2.  Munc18c: a controversial regulator of peripheral insulin action.

Authors:  Latha Ramalingam; Stephanie M Yoder; Eunjin Oh; Debbie C Thurmond
Journal:  Trends Endocrinol Metab       Date:  2014-07-12       Impact factor: 12.015

Review 3.  Hexosamines, insulin resistance, and the complications of diabetes: current status.

Authors:  Maria G Buse
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01       Impact factor: 4.310

4.  Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Kirk M Habegger; Alicia M McCarthy; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

Review 5.  Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.

Authors:  Victor M Darley-Usmar; Lauren E Ball; John C Chatham
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

Review 6.  Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4.

Authors:  Jenna L Jewell; Eunjin Oh; Debbie C Thurmond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-06       Impact factor: 3.619

7.  Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin.

Authors:  Guoli Chen; Priya Raman; Padma Bhonagiri; Andrew B Strawbridge; Guruprasad R Pattar; Jeffrey S Elmendorf
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

Review 8.  Modulation of insulin action.

Authors:  L Pirola; A M Johnston; E Van Obberghen
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

9.  The tyrosine phosphorylation of Munc18c induces a switch in binding specificity from syntaxin 4 to Doc2beta.

Authors:  Jenna L Jewell; Eunjin Oh; Sara M Bennett; Samy O Meroueh; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

10.  Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Emily M Horvath; Kirk M Habegger; Alicia M McCarthy; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.